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1Obstructive Sleep Apnea Syndrome (OSAS) and snoring are important health issues in the pediatric popu-
lation, with a respective prevalence of 0.1% to 13% and 6% to 12%1,2 and a strict correlation with recurrent 
upper airway disease1-3. Awareness of OSAS and snoring as health issues in children and adolescents is 
inadequate; there is a significant gap between the estimated number of children with OSAS and clinically 
diagnosed cases3. Missed or delayed treatment may put young patients at risk of growth lag, hyperactiv-
ity, attention deficit, learning disabilities, and low levels of education and literacy; there is a significant 
increase in the use of health services by children with OSAS4. Studies have demonstrated that the severity 
of OSAS correlates directly with total annual costs and is age-independent; other studies have shown that 
annual healthcare costs are reduced by one-third for children with OSAS undergoing adenotonsillectomy5,6.
The clinical picture of OSAS in children includes noisy breathing, habitual snoring with or without 
breathing pauses during sleep, enuresis, sleeping in the sitting position, cyanosis, headache on awaken-
ing, excessive daytime sleepiness, and higher prevalence of hyperactivity attention deficit and learning 
disorders2,4,7. Multidisciplinary approach plays a paramount role in OSAS; although a clinical suspicion 
can easily be formulated using a structured interview, diagnosis should be confirmed by a multidisci-
plinary team including pediatricians, ear-nose-throat specialists, and orthodontists2, with investigation 
of adenotonsillar hypertrophy, craniofacial dysmorphisms, oropharyngeal abnormalities (dental maloc-
clusions and jaw contraction), and obesity8, followed by polysomnography or less expensive objective 
testing (such as home sleep cardiorespiratory monitoring or night pulse oximetry) recently validated for 
diagnosis of OSAS in children8-10. 
By combining the clinical profile and the results of sleep testing, and taking into account the pre-
dominant risk factors for OSAS, children can be classified into different phenotypes: a) the “classical” 
phenotype, a child with adenotonsillar hypertrophy with or without dental and skeletal malocclusions; 
b) the “adult type” phenotype, characterized by obesity and associated with aspects of the classical phe-
notype; c) the “congenital” phenotype, with anomalies such as micrognathia or craniofacial alterations 
associated with genetic syndromes. The phenotype should guide the therapeutic choice, including med-
ical therapy (steroids and washing solutions administered as nasal spray and shower), bacteriotherapy, 
surgical therapy with adenoid and tonsil removal, orthodontic therapy, myofunctional treatment, and 
therapy with positive pressure devices2. 
Surgical therapy with adenotonsillectomy should be considered the first choice for children with 
severe OSAS and adenotonsillar hypertrophy, as indicated by clinical and objective testing criteria6. 
Immediate improvement may follow surgery, as measured by school performance and reduction of drug 
therapies. In the presence of comorbidities, adenotonsillectomy represents a first stage in the therapeutic 
program; in these cases, it is necessary to provide postsurgical follow-up in order to identify any patients 
who must undergo further treatment6. 
Orthopedic-orthodontic therapy is able to reduce the symptoms and alter the natural history of OSAS. 
This treatment can be integrated with both medical therapy and surgical therapy. Physiotherapists, speech 
therapists and nutritionists contribute to the implementation of therapy and long-term management of 
children with OSAS. 
In this supplement to the European Review For Medical and Pharmacological Sciences Journal, we invited 
contributions from different specialists to promote a multidisciplinary dissemination of research on OSAS, 
breathing-related sleep disorders, and recurrent upper airway disease in the pediatric age, with a special fo-
cus on each specialist’s approach to diagnosis and treatment of the issue and the role of recently-introduced 
bacteriotherapy for recurrent upper airway disease in the prevention and treatment of these conditions.
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